Literature DB >> 22192146

Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.

Yongfeng Wang1, Jin Cheng, Chunhui Xu, Shuang Liu, Suzhen Jiang, Qiang Xu, Xiangmei Chen, Hui Zhuang, Fengmin Lu.   

Abstract

BACKGROUND: Frequent promoter hypermethylation of the inhibitors in either Rb or p53 pathways is associated with the hepatocellular carcinoma (HCC) development.
OBJECTIVE: To quantitatively assess the gradual changes of the promoter methylation of p14ARF, p15INK4b, p16INK4a and CCND2 genes in hepatitis B virus (HBV) infection-related HCC.
METHODS: A total of 118 pairs of tumour and their corresponding non-tumour tissues were collected from HCC patients with evidence of HBV infection. The promoter methylation status was analysed by combined DNA methylation-sensitive and methylation-dependent restriction endonuclease digestion, followed by subsequential quantitative PCR assay.
RESULTS: Promoter hypermethylation frequencies were gradually increased from 6.25% in normal liver tissues to 21.19% in adjacent non-tumour and to 40.68% in tumour tissues for p16INK4a (P = 0.000), and from none to 10.20% and to 29.59% for CCND2 (P = 0.001). The hypermethylation intensities in HCC tissues were also significantly increased (P = 0.0018 for p16INK4a, P = 0.0001 for CCND2). Altogether, 48.93% cases were found with increased hypermethylation intensity of either p16INK4a and/or CCND2 promoter in tumour tissues, compared with their matched non-tumour tissues. In addition, tumour tissue p16INK4a promoter hypermethylation was significantly higher in male than that in female gender patients in frequency (P = 0.041) and was significantly increased in patients older than 50 years of age in intensity (P = 0.0021). No hypermethylation of p14ARF or p15INK4b was found.
CONCLUSION: Our study demonstrated that from normal liver to the adjacent cirrhotic liver and to the HCC tissues, p16INK4a hypermethylation was gradually increased both in frequency and in intensity, such increase might be gender and age related.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22192146     DOI: 10.1111/j.1478-3231.2011.02696.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  26 in total

1.  The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients.

Authors:  WenJie Yang; XiaoFeng Wang; XiaoWei Li; Min Wang; XiaoFeng Chen; XiaoMei Wu; YaPing Wang; YiMei Fan; HeiYing Jin
Journal:  Tumour Biol       Date:  2014-05-23

Review 2.  Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shan-Long Ding; Zi-Wei Yang; Jie Wang; Xiao-Lei Zhang; Xiang-Mei Chen; Feng-Min Lu
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma.

Authors:  Gengming Huang; Joseph D Krocker; Jason L Kirk; Shehzad N Merwat; Hyunsu Ju; Roger D Soloway; Lucas R Wieck; Albert Li; Anthony O Okorodudu; John R Petersen; Nihal E Abdulla; Andrea Duchini; Luca Cicalese; Cristiana Rastellini; Peter C Hu; Jianli Dong
Journal:  Clin Chem Lab Med       Date:  2014-06       Impact factor: 3.694

4.  Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

Authors:  Keisuke Amano; Takumi Kawaguchi; Ryoko Kuromatsu; Atsushi Kawaguchi; Ichiro Miyajima; Tatsuya Ide; Tatsuyuki Kakuma; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-08-21

Review 5.  P15 gene methylation in hepatocellular carcinomas: a systematic review and meta-analysis.

Authors:  Wei-Hua Ren; Ya-Wei Li; Rui Li; Hong-Bo Feng; Jun-Long Wu; Hui-Rui Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Wei-Cheng Liu; Quan-Yan Liu
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

7.  DNA methylation: potential biomarker in Hepatocellular Carcinoma.

Authors:  Way-Champ Mah; Caroline Gl Lee
Journal:  Biomark Res       Date:  2014-03-17

8.  Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9.

Authors:  Weihang Li; Ziyi Ding; Dong Wang; Chengfei Li; Yikai Pan; Yingjing Zhao; Hongzhe Zhao; Tianxing Lu; Rui Xu; Shilei Zhang; Bin Yuan; Yunlong Zhao; Yanjiang Yin; Yuan Gao; Jing Li; Ming Yan
Journal:  Cancer Cell Int       Date:  2021-07-14       Impact factor: 5.722

9.  PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma.

Authors:  J Lv; P Zhu; Z Yang; M Li; X Zhang; J Cheng; X Chen; F Lu
Journal:  J Viral Hepat       Date:  2014-06-09       Impact factor: 3.728

10.  An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.

Authors:  X Zhang; J Wang; J Cheng; S Ding; M Li; S Sun; L Zhang; S Liu; X Chen; H Zhuang; F Lu
Journal:  J Viral Hepat       Date:  2014-04       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.